Skip to content
Coming Soon·Opens soon·Synced from source July 5, 2026

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

National Institutes of Health

Posted
Feb 27, 2026
Closes
No deadline published by the funder
Last verified
Jul 5, 2026

Classification and identifiers

Solicitation number
RFA-EB-26-004
Assistance listing (CFDA)
93.286

Amount

Amount not published by the funder

Who can apply

Private universitiesSmall businessLocal governmentsFor-profitsNonprofits (non-501c3)School districts

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

About this opportunity

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

Finding similar opportunities...